Skip to main content
Erschienen in: Journal of Nuclear Cardiology 5/2010

01.10.2010 | Original Article

Patients with adenosine-induced ST-segment depressions and normal myocardial perfusion imaging: Cardiac outcomes at 24 months

verfasst von: Jyoti Sharma, MD, Christine Roncari, MD, Kenneth N. Giedd, MD, John T. Fox, MD, Yumiko Kanei, MD

Erschienen in: Journal of Nuclear Cardiology | Ausgabe 5/2010

Einloggen, um Zugang zu erhalten

Abstract

Background

The significance of ischemic ECG changes during adenosine infusion in patients with normal myocardial perfusion imaging (MPI) is controversial. We evaluated the prevalence of, and defined the predictors for, severe coronary artery disease (CAD) in patients with such discordant findings.

Methods

The findings of 3700 adenosine MPI studies performed at our institution between June 2005 and March 2009 were reviewed.

Results

Data for 76 patients who had not previously undergone coronary revascularization and who had sufficient follow-up were analyzed; 22 (29%) were referred for coronary angiography and 10 (13%) underwent revascularization. None had left main disease and only three (14%) had multivessel disease. Diabetes mellitus was more prevalent (70% vs. 23%; P = .010) and ischemic ST-segment depressions more often lasted >5 minutes (50% vs. 15%; P = 0.021) in patients undergoing revascularization. During a 24 ± 13 month follow-up period, there were no deaths or myocardial infarctions, while an eleventh patient underwent revascularization 19 months after MPI.

Conclusions

In the presence of normal MPI, the specificity of ischemic ECG changes during adenosine infusion for the detection of severe obstructive CAD is poor, although patients with multiple coronary risk factors, particularly diabetes mellitus, should undergo further investigation.
Literatur
1.
Zurück zum Zitat Kamal AM, Fattah AA, Pancholy S, Aksut S, Cave V, Heo J, et al. Prognostic value of adenosine single-photon emission computed tomographic thallium imaging in medically treated patients with angiographic evidence of coronary artery disease. J Nucl Cardiol 1994;1:254-61.CrossRefPubMed Kamal AM, Fattah AA, Pancholy S, Aksut S, Cave V, Heo J, et al. Prognostic value of adenosine single-photon emission computed tomographic thallium imaging in medically treated patients with angiographic evidence of coronary artery disease. J Nucl Cardiol 1994;1:254-61.CrossRefPubMed
2.
Zurück zum Zitat Cosmai E, Heller G. The clinical importance of electrocardiographic changes during pharmacologic stress testing with radionuclide myocardial perfusion imaging. J Nucl Cardiol 2005;12:466-72.CrossRefPubMed Cosmai E, Heller G. The clinical importance of electrocardiographic changes during pharmacologic stress testing with radionuclide myocardial perfusion imaging. J Nucl Cardiol 2005;12:466-72.CrossRefPubMed
3.
Zurück zum Zitat Marshall ES, Raicheln JS, Kim SM, Intenzo CM, Sawyer DT, Brody EA, et al. Prognostic significance of ST-segment depression during adenosine perfusion imaging. Am Heart J 1995;130:58-66.CrossRefPubMed Marshall ES, Raicheln JS, Kim SM, Intenzo CM, Sawyer DT, Brody EA, et al. Prognostic significance of ST-segment depression during adenosine perfusion imaging. Am Heart J 1995;130:58-66.CrossRefPubMed
4.
Zurück zum Zitat Abbott B, Afshar M, Berger A, Wackers F. Prognostic significance of ischemic electrocardiographic changes during adenosine infusion in patients with normal myocardial perfusion imaging. J Nucl Cardiol 2003;10:9-16.CrossRefPubMed Abbott B, Afshar M, Berger A, Wackers F. Prognostic significance of ischemic electrocardiographic changes during adenosine infusion in patients with normal myocardial perfusion imaging. J Nucl Cardiol 2003;10:9-16.CrossRefPubMed
5.
Zurück zum Zitat Klodas E, Miller TD, Christian TF, Hodge DO, Gibbons RJ. Prognostic significance of ischemic electrocardiographic changes during vasodilator stress testing in patients with normal SPECT images. J Nucl Cardiol 2003;10:4-8.CrossRefPubMed Klodas E, Miller TD, Christian TF, Hodge DO, Gibbons RJ. Prognostic significance of ischemic electrocardiographic changes during vasodilator stress testing in patients with normal SPECT images. J Nucl Cardiol 2003;10:4-8.CrossRefPubMed
6.
Zurück zum Zitat Hage F, Dubovsky E, Jaekyeong H, Iskandrian A. Outcome of patients with adenosine-induced ST-segment depression but with normal perfusion on tomographic imaging. Am J Cardiol 2006;98:1009-11.CrossRefPubMed Hage F, Dubovsky E, Jaekyeong H, Iskandrian A. Outcome of patients with adenosine-induced ST-segment depression but with normal perfusion on tomographic imaging. Am J Cardiol 2006;98:1009-11.CrossRefPubMed
7.
Zurück zum Zitat Hansen CL, Goldstein RA, Akinboboye OO, Berman DS, Botvinick EH, Churchwell KB, et al. ASNC imaging guidelines for nuclear cardiology imaging procedures. Myocardial perfusion and function: Single photon emission computed tomography. J Nucl Cardiol 2007;14:e39-60.CrossRefPubMed Hansen CL, Goldstein RA, Akinboboye OO, Berman DS, Botvinick EH, Churchwell KB, et al. ASNC imaging guidelines for nuclear cardiology imaging procedures. Myocardial perfusion and function: Single photon emission computed tomography. J Nucl Cardiol 2007;14:e39-60.CrossRefPubMed
8.
Zurück zum Zitat Johansen A, Høilund-Carlsen PF, Christensen HW, Vach W, Jørgensen HB, et al. Diagnostic accuracy of myocardial perfusion imaging in a study population without post-test referral bias. J Nucl Cardiol 2005;12:530-7.CrossRefPubMed Johansen A, Høilund-Carlsen PF, Christensen HW, Vach W, Jørgensen HB, et al. Diagnostic accuracy of myocardial perfusion imaging in a study population without post-test referral bias. J Nucl Cardiol 2005;12:530-7.CrossRefPubMed
9.
Zurück zum Zitat Chow BJ, Wong JW, Yoshinaga K, Ruddy TD, Williams K, deKemp R, et al. Prognostic significance of dipyridamole-induced ST depression in patients with normal 82Rb PET myocardial perfusion imaging. J Nucl Med 2005;46:1095-101.PubMed Chow BJ, Wong JW, Yoshinaga K, Ruddy TD, Williams K, deKemp R, et al. Prognostic significance of dipyridamole-induced ST depression in patients with normal 82Rb PET myocardial perfusion imaging. J Nucl Med 2005;46:1095-101.PubMed
10.
Zurück zum Zitat National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation 2002;106:3143-421. National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation 2002;106:3143-421.
11.
Zurück zum Zitat Kwok Y, Kim C, Grady D, Segal M, Redberg R. Meta-analysis of exercise testing to detect coronary artery disease in women. Am J Cardiol 1999;83:660-6.CrossRefPubMed Kwok Y, Kim C, Grady D, Segal M, Redberg R. Meta-analysis of exercise testing to detect coronary artery disease in women. Am J Cardiol 1999;83:660-6.CrossRefPubMed
12.
Zurück zum Zitat Henzlova MJ, Croft LB, Diamond JA. Effect of hormone replacement therapy on the electrocardiographic response to exercise. J Nucl Cardiol 2002;9:385-7.CrossRefPubMed Henzlova MJ, Croft LB, Diamond JA. Effect of hormone replacement therapy on the electrocardiographic response to exercise. J Nucl Cardiol 2002;9:385-7.CrossRefPubMed
13.
Zurück zum Zitat Tremmel JA, Yeung AC. Ischemic heart disease in women: An appropriate time to discriminate. Rev Cardiovascul Med 2007;8:61-8. Tremmel JA, Yeung AC. Ischemic heart disease in women: An appropriate time to discriminate. Rev Cardiovascul Med 2007;8:61-8.
14.
Zurück zum Zitat Pries AR, Habazettl H, Ambrosio G, Hansen PR, Kaski JC, Schachinger V, et al. A review of methods for assessment of coronary microvascular disease in both clinical and experimental settings. Cardiovasc Res 2008;80:165-74.CrossRefPubMed Pries AR, Habazettl H, Ambrosio G, Hansen PR, Kaski JC, Schachinger V, et al. A review of methods for assessment of coronary microvascular disease in both clinical and experimental settings. Cardiovasc Res 2008;80:165-74.CrossRefPubMed
Metadaten
Titel
Patients with adenosine-induced ST-segment depressions and normal myocardial perfusion imaging: Cardiac outcomes at 24 months
verfasst von
Jyoti Sharma, MD
Christine Roncari, MD
Kenneth N. Giedd, MD
John T. Fox, MD
Yumiko Kanei, MD
Publikationsdatum
01.10.2010
Verlag
Springer-Verlag
Erschienen in
Journal of Nuclear Cardiology / Ausgabe 5/2010
Print ISSN: 1071-3581
Elektronische ISSN: 1532-6551
DOI
https://doi.org/10.1007/s12350-010-9259-6

Weitere Artikel der Ausgabe 5/2010

Journal of Nuclear Cardiology 5/2010 Zur Ausgabe

Screening-Mammografie offenbart erhöhtes Herz-Kreislauf-Risiko

26.04.2024 Mammografie Nachrichten

Routinemäßige Mammografien helfen, Brustkrebs frühzeitig zu erkennen. Anhand der Röntgenuntersuchung lassen sich aber auch kardiovaskuläre Risikopatientinnen identifizieren. Als zuverlässiger Anhaltspunkt gilt die Verkalkung der Brustarterien.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 Hypertonie Nachrichten

Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.

Adipositas-Medikament auch gegen Schlafapnoe wirksam

24.04.2024 Adipositas Nachrichten

Der als Antidiabetikum sowie zum Gewichtsmanagement zugelassene Wirkstoff Tirzepatid hat in Studien bei adipösen Patienten auch schlafbezogene Atmungsstörungen deutlich reduziert, informiert der Hersteller in einer Vorab-Meldung zum Studienausgang.

Update Kardiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.